Veracyte, Inc. (VCYT) — Business segments and KPIs
Revenue by business segment and geography for Veracyte, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Testing | 493.15M | 95.4% |
| Product | 14.33M | 2.8% |
| Biopharmaceutical And Other | 9.66M | 1.9% |
| Revenue by region | ||
| UNITED STATES | 496.6M | 96.0% |
| Non-US | 20.55M | 4.0% |